{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreieozbsy765zccwkn6uo2zqdntiocduwhqkzetxu4plhsp46jd6sxq",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mm62zayk6y32"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifn6p5zobky53df2xtibsmyd4hripi3t3tcjbfvz2yezykej4d5rq"
    },
    "mimeType": "image/jpeg",
    "size": 132595
  },
  "path": "/news/2026-05-fda-blocked-melanoma-drug-makary.html",
  "publishedAt": "2026-05-18T19:40:06.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "The U.S. Food and Drug Administration's decision to withhold approval of a new skin cancer treatment fell like a hammer on doctors who treat melanoma and patients who saw that the drug had prolonged the lives of a third of the participants in a clinical trial.",
  "title": "FDA blocked melanoma drug as confusion reigned under Makary"
}